Zivo Bioscience (ZIVO)

$10.25 0.00 (N/A)
Market Cap 40.77M
Revenue (ttm) 160,000.00
Net Income (ttm) -13.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,362.50%
Debt to Equity Ratio 0.00
Volume 400
Avg Vol 1,326
Day's Range N/A - N/A
Shares Out 3.98M
Stochastic %K 53%
Beta 0.19
Analysts Hold
Price Target $12.00

Company Profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 248 452 9866
Address:
2125 Butterfield Drive, Suite 100, Troy, United States
trprofit
trprofit Feb. 23 at 10:53 PM
$ZIVO "Signed deal during the first quarter" Could they have meant THIS year?
1 · Reply
nick275
nick275 Feb. 19 at 3:54 PM
$ZIVO I look at my portfolio YTD, 1 year, and 5 year full of green and then there is ZIVO.
0 · Reply
trprofit
trprofit Feb. 17 at 5:08 PM
$ZIVO Staying alive...staying alive
1 · Reply
nick275
nick275 Feb. 17 at 2:30 PM
$ZIVO based on recent filings, it appears the top six beneficial holders collectively control almost 70% of outstanding shares • Laith Yaldoo — 560,272 • Christopher Maggiore — 511,382 • Mark Strome — 476,854 • Keith Marchiando — 431,056 • John Payne — 311,807 • Alison Cornell — 271,471 That level of concentration means a very small group effectively controls the company. What prevents insiders with this much ownership from taking the company private at a depressed valuation? This is why I hesitate to buy.
1 · Reply
nick275
nick275 Feb. 10 at 12:57 PM
$ZIVO It appears 3,174,000 warrants were issued under ZIVOW. These are trading at close to $0 and expire worthless the end of April. I have to believe the deliberate withholding of information from the public by ZIVO insiders is tied to the warrants expiring. Warrants issued to Armistice expired worthless last year.
0 · Reply
nick275
nick275 Feb. 10 at 3:05 AM
$ZIVO I assume no news until ZIVOW warrants expire worthless the end of April. Curious who still holds these. Guessing the board got rid of what they received. These were trading at over $1.50 with decent volume the end of 2024.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 28 at 11:10 PM
$ZIVO CEO purchased 11,709 shares at $8.54 for a total of $99,995. PAYNE JOHN BERNARD now owns 19,618 shares. https://ceo-buys.com
0 · Reply
nick275
nick275 Jan. 22 at 12:35 PM
$ZIVO CEO John Payne at Mar a Lago. That silly party with people dressed as dogs at Mar a Lago was hosted by Humane Society led by $ZIVO CEO John Payne. Hopefully he has the President’s attention. https://www.ibtimes.co.uk/trumps-latest-mar-lago-party-features-let-them-eat-cake-theme-dog-masked-rococo-dancers-1771182
1 · Reply
trprofit
trprofit Jan. 17 at 4:53 PM
$ZIVO So did anyone else note any change? Zivo Bioscience, Inc. https://www.zivobioscience.com 4 days ago (Jan 13) — A US-based R&D firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules. Copyright 2026 on website
2 · Reply
trprofit
trprofit Jan. 15 at 8:10 PM
$ZIVO So nothing 2025 first quarter... Could they have meant 1st Q 2026 Are they ever gonna sign a deal or what?? How long can they draw this out? Time will tell
3 · Reply
Latest News on ZIVO
No data available.
trprofit
trprofit Feb. 23 at 10:53 PM
$ZIVO "Signed deal during the first quarter" Could they have meant THIS year?
1 · Reply
nick275
nick275 Feb. 19 at 3:54 PM
$ZIVO I look at my portfolio YTD, 1 year, and 5 year full of green and then there is ZIVO.
0 · Reply
trprofit
trprofit Feb. 17 at 5:08 PM
$ZIVO Staying alive...staying alive
1 · Reply
nick275
nick275 Feb. 17 at 2:30 PM
$ZIVO based on recent filings, it appears the top six beneficial holders collectively control almost 70% of outstanding shares • Laith Yaldoo — 560,272 • Christopher Maggiore — 511,382 • Mark Strome — 476,854 • Keith Marchiando — 431,056 • John Payne — 311,807 • Alison Cornell — 271,471 That level of concentration means a very small group effectively controls the company. What prevents insiders with this much ownership from taking the company private at a depressed valuation? This is why I hesitate to buy.
1 · Reply
nick275
nick275 Feb. 10 at 12:57 PM
$ZIVO It appears 3,174,000 warrants were issued under ZIVOW. These are trading at close to $0 and expire worthless the end of April. I have to believe the deliberate withholding of information from the public by ZIVO insiders is tied to the warrants expiring. Warrants issued to Armistice expired worthless last year.
0 · Reply
nick275
nick275 Feb. 10 at 3:05 AM
$ZIVO I assume no news until ZIVOW warrants expire worthless the end of April. Curious who still holds these. Guessing the board got rid of what they received. These were trading at over $1.50 with decent volume the end of 2024.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 28 at 11:10 PM
$ZIVO CEO purchased 11,709 shares at $8.54 for a total of $99,995. PAYNE JOHN BERNARD now owns 19,618 shares. https://ceo-buys.com
0 · Reply
nick275
nick275 Jan. 22 at 12:35 PM
$ZIVO CEO John Payne at Mar a Lago. That silly party with people dressed as dogs at Mar a Lago was hosted by Humane Society led by $ZIVO CEO John Payne. Hopefully he has the President’s attention. https://www.ibtimes.co.uk/trumps-latest-mar-lago-party-features-let-them-eat-cake-theme-dog-masked-rococo-dancers-1771182
1 · Reply
trprofit
trprofit Jan. 17 at 4:53 PM
$ZIVO So did anyone else note any change? Zivo Bioscience, Inc. https://www.zivobioscience.com 4 days ago (Jan 13) — A US-based R&D firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules. Copyright 2026 on website
2 · Reply
trprofit
trprofit Jan. 15 at 8:10 PM
$ZIVO So nothing 2025 first quarter... Could they have meant 1st Q 2026 Are they ever gonna sign a deal or what?? How long can they draw this out? Time will tell
3 · Reply
nick275
nick275 Jan. 10 at 7:04 PM
$ZIVO Another investor shared with me AG1 is now a billion dollar company and growing fast. Zivo had a ten year head start on AG1in this space and has a $30 million market cap. Critics faulted AG1 for not spending more on validation tests. They spent their money on marketing and sales. Now AG1 has made their investors wealthy while the only people who made money from Zivo are researchers who bring in no revenue and former c-suite executives getting paid not to work.
1 · Reply
S2h7o
S2h7o Dec. 23 at 9:44 PM
$ZIVO Way to go Zivo. Filing today that your CFO has resigned. Everyone can form their own opinions on that, but as for me what a wasted investment you have been.
1 · Reply
nick275
nick275 Dec. 19 at 3:39 PM
$ZIVO sad what this has become after so much promise 12 months ago. Hard to believe we are ending the year with no revenue from licensing.
1 · Reply
S2h7o
S2h7o Dec. 11 at 10:32 AM
$ZIVO as another year winds down Zivo is chalking up another year of nothingness. I would love for my sentiments to be proven wrong, but I’m not holding my breath and absolutely will be voting “NO!” with my shares against the board’s meaningless value consuming proposals and recommendations. Happy holidays!
2 · Reply
trprofit
trprofit Dec. 3 at 1:38 PM
$ZIVO Yaldo is keepin the light on...for now. WTF is happening ZIVO??
1 · Reply
trprofit
trprofit Nov. 26 at 12:46 PM
$ZIVO Make it happen Yaldo! YOU have the most to lose here.
1 · Reply
nick275
nick275 Nov. 23 at 8:26 PM
$ZIVO CEO Payne has repeated the same pattern that plagued Zivo before he arrived: big promises, firm timelines, and no executed deal. In 2022, Payne said Zivo expected a final call from a leading partner by the end of the second quarter. Nothing happened. In 2023, the company suggested that diligence was nearly complete. Still nothing. By 2024, Zivo pointed to strong data from a key 42-day poultry trial and hinted that negotiations were entering their final phase. Again, no agreement. The latest pledge was that formal talks would begin in January 2025 and wrap up soon after. As of the most recent updates, investors are still waiting. For a CEO whose message centers on operational discipline and commercial readiness, the repeated slips raise questions about how close these deals ever were. Either the counterparties are unconvinced, or Zivo has overestimated its leverage. Both possibilities point to deeper issues.
0 · Reply
nick275
nick275 Nov. 23 at 5:16 PM
$ZIVO price falling and volume increasing. Someone knows something. Is ZIVO withholding material information?
0 · Reply
nick275
nick275 Nov. 23 at 2:17 PM
$ZIVO now in the single digits. Ready to submit an open records request to the University of Delaware to see what is going on with their work with Zivo since Zivo will not communicate with investors.
0 · Reply
nick275
nick275 Nov. 20 at 2:47 PM
$ZIVO still nothing while price approaches single digits. The incompetence is astonishing
1 · Reply
nick275
nick275 Nov. 2 at 11:03 PM
$ZIVO anyone here still holding ? Appears no progress made since CEO letter. So many other opportunities in the market while this has drifted down and been dead money for years.
0 · Reply
nick275
nick275 Oct. 29 at 6:16 PM
$ZIVO and the bid collapses. Just another day in Zivoland
0 · Reply